Literature DB >> 10523588

Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility.

J L Rowen1, J M Tate, N Nordoff, L Passarell, M R McGinnis.   

Abstract

Systemic candidiasis affects 1.6 to 4.5% of very low birth weight (</= 1,500 g) infants. A specimen archive of Candida strains from intensive care nurseries was created; it currently houses 98 isolates from 17 institutions. Eight isolates (8.2%) were misidentified at the referring institution. The MICs of fluconazole for seven isolates (7.1%, all non-C. albicans species, one misidentified initially) were >8 microg/ml.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10523588      PMCID： PMC85744     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

1.  Mucocutaneous and invasive candidiasis among very low birth weight (less than 1,500 grams) infants in intensive care nurseries: a prospective study.

Authors:  R G Faix; S M Kovarik; T R Shaw; R V Johnson
Journal:  Pediatrics       Date:  1989-01       Impact factor: 7.124

Review 2.  Candida: an increasingly important pathogen in the nursery.

Authors:  K M Butler; C J Baker
Journal:  Pediatr Clin North Am       Date:  1988-06       Impact factor: 3.278

Review 3.  Antifungal agents in neonatal systemic candidiasis.

Authors:  J N van den Anker; N M van Popele; P J Sauer
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

4.  Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life.

Authors:  H Saxén; K Hoppu; M Pohjavuori
Journal:  Clin Pharmacol Ther       Date:  1993-09       Impact factor: 6.875

5.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

Authors:  M H Nguyen; J E Peacock; A J Morris; D C Tanner; M L Nguyen; D R Snydman; M M Wagener; M G Rinaldi; V L Yu
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

6.  Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study.

Authors:  D E Weese-Mayer; D W Fondriest; R T Brouillette; S T Shulman
Journal:  Pediatr Infect Dis J       Date:  1987-02       Impact factor: 2.129

7.  Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology.

Authors:  J E Baley; R M Kliegman; A A Fanaroff
Journal:  Pediatrics       Date:  1984-02       Impact factor: 7.124

8.  Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.

Authors:  J H Rex; M A Pfaller; A L Barry; P W Nelson; C D Webb
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

9.  Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement.

Authors:  R G Faix
Journal:  J Pediatr       Date:  1984-10       Impact factor: 4.406

10.  Invasive fungal dermatitis in the < or = 1000-gram neonate.

Authors:  J L Rowen; J T Atkins; M L Levy; S C Baer; C J Baker
Journal:  Pediatrics       Date:  1995-05       Impact factor: 7.124
View more
  14 in total

1.  Comparison of API20C with molecular identification of Candida spp isolated from bloodstream infections.

Authors:  J Xu; B C Millar; J E Moore; R McClurg; M J Walker; J Evans; S Hedderwick; R McMullan
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

2.  Population pharmacokinetics of amphotericin B lipid complex in neonates.

Authors:  Gudrun Würthwein; Andreas H Groll; Georg Hempel; Felice C Adler-Shohet; Jay M Lieberman; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes.

Authors:  K Oliveira; G Haase; C Kurtzman; J J Hyldig-Nielsen; H Stender
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species.

Authors:  Rasmus H Jensen; Maiken C Arendrup
Journal:  J Clin Microbiol       Date:  2010-12-08       Impact factor: 5.948

5.  Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.

Authors:  E Roilides; E Farmaki; J Evdoridou; J Dotis; E Hatziioannidis; M Tsivitanidou; E Bibashi; I Filioti; D Sofianou; C Gil-Lamaignere; F-M Mueller; G Kremenopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

Review 6.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

7.  Management of neonatal candidiasis. Neonatal Candidiasis Study Group.

Authors:  J L Rowen; J M Tate
Journal:  Pediatr Infect Dis J       Date:  1998-11       Impact factor: 2.129

8.  Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories.

Authors:  A M Freydiere; J D Perry; O Faure; B Willinger; A M Tortorano; A Nicholson; J Peman; P E Verweij
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Isolation of fluconazole-tolerant micromycetes onto different cultivation media.

Authors:  Z Kunová; E Piecková
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

Review 10.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.